Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Abstract Introduction The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/Spondyloarthritis Registry. Methods Participants wi...

Full description

Bibliographic Details
Main Authors: Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-08-01
Series:Rheumatology and Therapy
Subjects:
Psoriatic arthritis
Biologics
Guselkumab
Real-world evidence
Online Access:https://doi.org/10.1007/s40744-023-00582-w

Internet

https://doi.org/10.1007/s40744-023-00582-w

Similar Items